Pandemic preparedness beyond COVID-19 (in partnership with the World Health Organization)
Date: Thursday, 21 October 2021
For a summary report of this session, please click here.
The current pandemic has highlighted the exposure of LMICs to global vaccine supply shortages, despite efforts by the industry to increase manufacturing capacity, including in large developing countries. This challenge extends well beyond COVID-19. Routine vaccination programs need to be maintained in LMICs to avoid increased mortality, especially among children. Building productive capacity in developing countries for vaccines beyond COVID-19 could make an important contribution to equitable access and pandemic preparedness in LMICs. Increased global cooperation is essential to achieve this goal.
At a World Investment Forum satellite event on 3 March 2021, UNCTAD in partnership with WHO launched a series of consultations with policymakers, investors, vaccine manufacturers and technology providers on how to coordinate and promote investment in LMIC-based vaccine productive capacity. The event involved major actors in the international COVID-19 response such as, inter alia, the Coalition for Epidemic Preparedness Innovations, International Finance Corporation, Bill & Melinda Gates Foundation, African Development Bank and Serum Institute of India. The purpose of this event is to report on these consultations, take stock of partnerships to date and discuss the way forward in intensifying partnerships for vaccine productive capacity.
- Ms. Isabelle Durant, Deputy Secretary General, UNCTAD
- Dr. Rogério Gaspar, Director, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization
Presentation: Key development on partnership for production of vaccines in LMICs
- Mr. Martin Seychell, Deputy Director-General, Directorate-General for International Partnerships, Responsible for Directorates G and R, European Commission
- Mr. Nicaise Ndembi, Senior Science Advisor to the Africa CDC Director
Roundtable discussion: Taking stock of the status of partnership for production of vaccines in LMICs and the way forward
- Mr. Matthew Downham, Sustainable Manufacturing Lead, Coalition for Epidemic Preparedness Innovations (CEPI)
- Mr. Patrick Tippoo, Executive Director, African Vaccine Manufacturing Initiative (AVMI)
- Dr. Abdu Mukhtar, Director, Industrial and Trade Development Department, African Development Bank (AfDB)
Commentary and discussion: Status of partnership for production of vaccines in LMICs and the way forward:
- Mr. David Robinson, Deputy Director, CMC Vaccines Development and Surveillance, Bill & Melinda Gates Foundation (BMGF)
- Mr. Axel Klaphake, Director Economic and Social Development, Digitalization Sector and Global Programmes, Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
- Mr. Stephen N. Karingi, Director, Regional Integration and Trade Division, United Nations Economic Commission for Africa
- Dr. Jicui Dong, Head, Local Production and Assistance Unit, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organisation
- Mr. Ermias Biadgleng, Officer-in-Charge, Intellectual Property Unit, UNCTAD
Event manager: Mr. Ermias Biadgleng
Contact email: Ermias.Biadgleng@unctad.org